How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Rebecca Ferguson's critically acclaimed sci-fi series, Silo, has returned with a bang on Apple TV. The show is now nearing a ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

Rohan Naahar is a News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has covered everything from Marvel to the Oscars, and Marvel at the Oscars. He also ...

Learn how drawing from fixed income first can reduce sequence risk, stabilize retirement income, and protect long-term ...